Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)

Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE)... Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approved by Japanese Society of Nuclear Medicine. Lu-177-DOTA-TATE treatment in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown in this guideline are considered internationally useful as well. Only the original Japanese version is the formal document. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Nuclear Medicine Springer Journals

Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)

19 pages
Read Article

Loading next page...
 
/lp/springer_journal/manual-on-the-proper-use-of-lutetium-177-labeled-somatostatin-analogue-0FcS90NEui
Publisher
Springer Japan
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology
ISSN
0914-7187
eISSN
1864-6433
D.O.I.
10.1007/s12149-018-1230-7
Publisher site
See Article on Publisher Site

Abstract

Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approved by Japanese Society of Nuclear Medicine. Lu-177-DOTA-TATE treatment in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown in this guideline are considered internationally useful as well. Only the original Japanese version is the formal document.

Journal

Annals of Nuclear Medicine – Springer Journals

Published: Jan 15, 2018

References

  • [177Lu-DOTA0-Tyr3]-octreotate treatment in patients with disseminated gastroenteropancreatic neuroendocrine tumors: The value of measuring absorbed dose to the kidney
    Swärd, C; Bernhardt, P; Ahlman, H; Wängberg, B; Forssell-Aronsson, E; Larsson, M
  • Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate: toxicity, efficacy, and survival
    Kwekkeboom, D; Herder, W; Kam, B; Eijck, C; Essen, M; Kooij, P
  • Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I–II study
    Bodei, L; Cremonesi, M; Grana, CM; Fazio, N; Iodice, S; Baio, SM
  • Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC
    Wehrmann, C; Senftleben, S; Zachert, C; Müller, D; Baum, RP
  • Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment
    Sandström, M; Garske-Román, U; Granberg, D; Johansson, S; Widstrom, C; Eriksson, B
  • Criteria for discharge of patients undergoing 131I treatment and criteria for release to regular patient rooms based on the dose of external exposure
    Koshida, K; Koga, S
  • Clearance of 177Lu-DOTATATE from patients receiving peptide receptor radionuclide therapy
    Archer, J; Carroll, M; Vinjamuri, S
  • Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis
    Ito, T; Igarashi, H; Nakamura, K; Sasano, H; Okusaka, T; Takano, K
  • The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
    John, J; Zaknun, L; Bodei, J; Mueller-Brand, ME; Pavel, RP; Baum, D; Horsch

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off

Sign up
for free
Start 14 day
Free Trial